SCHEMBL2409730

SCHEMBL2409730

O[C@@H]1[C@@H](O)[C@@H](Oc2cccc(-c3ccccn3)c2)SC[C@H]1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
LMNA P02545 3/20 0.36
HPGD P15428 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
DCTPP1 Q9H773 1/20 0.36
HTR1A P08908 1/20 0.36
HTR7 P34969 1/20 0.36
GRM5 P41594 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
PKM P14618 1/20 0.36
RAB9A P51151 1/20 0.36
PDK2 Q15119 1/20 0.35
ABL1 P00519 2/20 0.35
FFAR1 O14842 1/20 0.35
BCR P11274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2409726 1.00 PRMT5 (0.38) PRMT5WDR77LMNAHPGDL3MBTL1
SCHEMBL2410690 0.86 CLK4 (0.46) TDP1ADORA3
SCHEMBL2411771 0.86 CYP1A2 (0.42) LMNAL3MBTL1MEN1KMT2ADCTPP1
SCHEMBL2411775 0.86 CYP1A2 (0.42) LMNAL3MBTL1MEN1KMT2ADCTPP1
SCHEMBL2410694 0.86 CLK4 (0.46) TDP1ADORA3
SCHEMBL2413299 0.86 ADORA3 (0.37) ADORA3
SCHEMBL2413297 0.86 ADORA3 (0.37) ADORA3
SCHEMBL2413805 0.86 PRMT5 (0.39) PRMT5WDR77ABL1ADORA3
SCHEMBL2413812 0.86 PRMT5 (0.39) PRMT5WDR77ABL1ADORA3
SCHEMBL2417193 0.85 ABL1 (0.39) LMNAHPGDL3MBTL1MEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8013010-B2 5-thioxylopyranose compounds LABORATOIRES FOURNIER S.A. (FR) 2011-09-06 US disclosed
US-20090186840-A1 5-Thioxylopyranose Compounds LABORATOIRES FOURNIER S.A (FR) 2009-07-23 US disclosed
EP-2066681-A1 NEW DERIVATIVES OF 5-THIOXILOPYRANOSE LABORATOIRES FOURNIER SA (FR) 2009-06-10 EP disclosed
WO-2008037923-A1 NEW DERIVATIVES OF 5-THIOXILOPYRANOSE LABORATOIRES FOURNIER S.A. (FR) 2008-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186840-A1 5-Thioxylopyranose Compounds TPMT, PNPO, CYP3A5 PRMT5 961/4885WDR77 3751/4885LMNA 3890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.